Literature DB >> 1554631

Can patients wash during radiotherapy to the breast or chest wall? A randomized controlled trial.

I R Campbell1, M H Illingworth.   

Abstract

A total of 99 patients receiving adjuvant radiotherapy to the breast or chest wall were randomized to one of three washing policies: (1) not washing, (2) washing with water alone, and (3) washing with soap and water. Fifty-three of the patients were treated without the use of bolus, and 46 patients were treated using bolus for 10 to 15 of the 20 treatment fractions. Approximately half of the patients randomized to washing were tattooed. Subjective and objective measurements of acute skin reactions were found to be less in the two groups randomized to washing. There was little difference between the two washing groups. These findings were the same whether or not bolus was used. It is concluded that washing of the skin should be encouraged in patients undergoing radiotherapy associated with low skin doses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1554631     DOI: 10.1016/s0936-6555(05)80971-9

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  16 in total

Review 1.  The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline.

Authors:  Amanda Bolderston; Nancy S Lloyd; Rebecca K S Wong; Lori Holden; Linda Robb-Blenderman
Journal:  Support Care Cancer       Date:  2006-06-07       Impact factor: 3.603

Review 2.  Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group.

Authors:  Rebecca K S Wong; René-Jean Bensadoun; Christine B Boers-Doets; Jane Bryce; Alexandre Chan; Joel B Epstein; Beth Eaby-Sandy; Mario E Lacouture
Journal:  Support Care Cancer       Date:  2013-08-14       Impact factor: 3.603

Review 3.  [Prevention and therapy of acute radiation-related morbidity of the skin and mucosa. II, Recommendations of the literature].

Authors:  J S Zimmermann; P Niehoff; R Wilhelm; R Schneider; G Kovács; B Kimmig
Journal:  Strahlenther Onkol       Date:  1998-04       Impact factor: 3.621

4.  Trolamine emulsion for the prevention of radiation dermatitis in patients with squamous cell carcinoma of the head and neck.

Authors:  Hamza Abbas; René-Jean Bensadoun
Journal:  Support Care Cancer       Date:  2011-02-22       Impact factor: 3.603

5.  Radiodermatitis prevention with sucralfate in breast cancer: fundamental and clinical studies.

Authors:  Sabrina Falkowski; Patrick Trouillas; Jean-Luc Duroux; Jean-Marie Bonnetblanc; Pierre Clavère
Journal:  Support Care Cancer       Date:  2009-12-09       Impact factor: 3.603

Review 6.  A systematic review of patient-rated measures of radiodermatitis in breast cancer radiotherapy.

Authors:  Julie B Schnur; Bianca Love; Bari L Scheckner; Sheryl Green; A Gabriella Wernicke; A Gabriella; Guy H Montgomery
Journal:  Am J Clin Oncol       Date:  2011-10       Impact factor: 2.339

7.  A Dermatitis Control Program (DeCoP) for head and neck cancer patients receiving radiotherapy: a prospective phase II study.

Authors:  Sadamoto Zenda; Shinobu Ishi; Mitsuhiko Kawashima; Satoko Arahira; Makoto Tahara; Ryuichi Hayashi; Seiji Kishimoto; Tomiko Ichihashi
Journal:  Int J Clin Oncol       Date:  2012-02-15       Impact factor: 3.402

8.  Dermatologic Toxicities from Monoclonal Antibodies and Tyrosine Kinase Inhibitors against EGFR: Pathophysiology and Management.

Authors:  Shaad E Abdullah; Missak Haigentz; Bilal Piperdi
Journal:  Chemother Res Pract       Date:  2012-09-11

Review 9.  Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.

Authors:  Mario E Lacouture; Milan J Anadkat; René-Jean Bensadoun; Jane Bryce; Alexandre Chan; Joel B Epstein; Beth Eaby-Sandy; Barbara A Murphy
Journal:  Support Care Cancer       Date:  2011-06-01       Impact factor: 3.603

10.  A quantitative approach to the distress caused by symptoms in patients treated with radical radiotherapy.

Authors:  A J Munro; S Potter
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.